factually
Index/Topics/Mesoblast products

Mesoblast products

Mesoblast develops mesenchymal-lineage cell therapies and has product names such as Ryoncil and Rexlemestrocel-L.

Fact-Checks

2 results
Jan 17, 2026
Most Viewed

How does Memoblast's safety profile compare to alternative treatments for the same condition?

Two distinct products appear under the “Memoblast/MemoBlast” name in the supplied reporting, and their safety evidence is not interchangeable: an investigational mesenchymal cell therapy for degenerat...

Jan 15, 2026

Have regulators (FDA, EMA) reviewed or approved Memoblast and what did they report?

The U.S. Food and Drug Administration reviewed and granted approval to Mesoblast’s remestemcel‑L, branded Ryoncil, for steroid‑refractory acute graft‑versus‑host disease (SR‑aGVHD) in pediatric patien...